OCGN•benzinga•
Ocugen Announces Preliminary Data For OCU410l; Findings Included No Drug-related Serious Adverse Events, Reduced Lesion Growth, Preservation Of Retinal Tissue, Positive Effect On The Functional Visual Measure Of Low Luminance Visual Acuity
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 19, 2024 by benzinga